On 14th June 2023, Neuroendocrine Cancer UK, alongside The Health Policy Partnership and a group of dedicated supporters, travelled to Parliament to share the neuroendocrine cancer: ideal patient care pathway with MPs. The pathway was created to address the persistent...
We need your support! ๐ค The time for us to come together and make a difference is upon us๐ We can influence meaningful change by mobilising our collective voices and amplifying our need for support. One of the most effective ways to achieve this is by contacting...
The North of England Regional Natter Group is pleased to invite all to a special Webinar-Natter: 21st June 2023 A patient’s perspective on clinical trials and research: Kate Quirk Many of you may know Kate. She is our Cancer Support Coordinator: providing peer...
Neuroendocrine cancers (NC) are Englandโs tenth most prevalent cancer. Yet awareness of these cancers is very low, even among healthcare professionals (HCPs). People living with NC experience inequities in diagnosis, disease management and care due to a lack of...
Neuroendocrine cancer is a cancer that originates in the neuroendocrine system, which is responsible for producing hormones that regulate various bodily functions. While neuroendocrine tumors can arise in various parts of the body, including the pancreas, lungs, and...
